Health Canada approves secukinumab for psoriatic arthritis, ankylosing spondylitis

This entry was posted by ctbenefits on April 29, 2016 at 8:46 pm

Health Canada approves secukinumab for psoriatic arthritis, ankylosing spondylitis

Secukinumab has been approved by Health Canada for adult patients with psoriatic arthritis or ankylosing spondylitis who responded inadequately to prior treatment with conventional therapy, according to a press release from Novartis.

(Visited 4 times, 1 visits today)
Click here to read the full article
1
Like
Save

Comments

Write a comment